We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Latent Toxoplasmosis Prevalence Analyzed Retrospectively

By LabMedica International staff writers
Posted on 01 Sep 2016
Primary maternal infection with Toxoplasma gondii during pregnancy can lead to prenatal infection of the unborn child, and vertical diaplacental transmission of Toxoplasma can seriously damage the embryo. More...
Some prenatally infected children, asymptomatic at birth, can develop retinochorioiditis and other sequelae months or years later.

In Austria, mandatory screening for the prevention of congenital toxoplasmosis stipulates a serological test for antibodies against T. gondii as early as possible in pregnancy. In the case of a seronegative result, subsequent tests at intervals of eight weeks are requested. If antibodies against the parasites are detected, the sample is further tested for specific immunoglobulin M (IgM) antibodies. A negative IgM report indicates a late latent infection that poses no threat for the current pregnancy.

A team of scientists collaborating with the Labor Dr. Berghold (Graz, Austria) analyzed serological data from Styria, an Austrian federal state, to determine the sero-prevalence and incidence of Toxoplasma infections. The study included 353,599 tests from 103,316 women during 158,571 pregnancies from 1995 to 2012.

Three different test systems were used to screen for antibodies against T. gondii: from January 1, 1995, to June 18, 2006, the team used slides coated with T. gondii for indirect immunofluorescence test (IIFT). From June 19, 2006, to December 5, 2010, the determinations were made with the automated Vidas Toxo IgG System (bioMérieux, Marcy-l'Étoile, France). Since December 6, 2010, Toxoplasma IgG has been determined automatically using the Architect System (Abbott Diagnostics, Lake Forest, IL, USA). Toxoplasma IgM test to confirm seroconversion was determined with the following systems: the automated bioMérieux Vidas Toxo IgM System; the bioMérieux automated Vidia IgM assay; and since December 6, 2010, the automated Architect System IgM assay from Abbott Diagnostics.

The scientists found that the age-adjusted sero-prevalence decreased from 43.3% in 1995 to 31.5% in 2012, with a yearly decline of 0.84%. The intergravid incidence showed an annual decrease of 4.2%. The average yearly incidence of intragravid and intergravid seroconversions was 0.52% and 0.72%, respectively. Therefore it is to be expected that the sero-prevalence of latent Toxoplasma infections will continue to show a clear decrease. That means, however, that the number of women of childbearing age who are at risk of infection will increase. The net effect is that although primary infections in pregnancy are decreasing, prenatal toxoplasmosis will continue to pose a substantial threat to pregnant women and their children.

The main source of human Toxoplasma infections is seen to be consumption of undercooked meat and meat products. Modern technology in meat processing may have reduced the degree of contamination, and hygiene measures such as strict rodent control and cats in livestock barns help to reduce infection pressure. Deep-freezing meat for a number of days also helps to kill T. gondii. For some years, however, there has been a trend towards organic and free-range farming, and in such operations, there is a higher sero-prevalence of infection. The study was published on August 18, 2016, in the journal Eurosurveillance.

Related Links:
Labor Dr. Berghold
bioMérieux
Abbott Diagnostics

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
DNA Extraction Kit
MagMAX DNA Multi-Sample Ultra 2.0 Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.